Vitrolife AB
SWB:VTFN

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
SWB:VTFN
Watchlist
Price: 12.24 EUR 0.41% Market Closed
Market Cap: 5.4B EUR

Wall Street
Price Targets

VTFN Price Targets Summary
Vitrolife AB

Wall Street analysts forecast VTFN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTFN is 16.77 EUR with a low forecast of 14.22 EUR and a high forecast of 21.26 EUR.

Lowest
Price Target
14.22 EUR
16% Upside
Average
Price Target
16.77 EUR
37% Upside
Highest
Price Target
21.26 EUR
74% Upside
Vitrolife AB Competitors:
Price Targets
EVAX
Evaxion Biotech A/S
149% Upside
1530
3SBio Inc
43% Upside
BMEA
Biomea Fusion Inc
467% Upside
688520
Sinocelltech Group Ltd
21% Upside
APLS
Apellis Pharmaceuticals Inc
51% Upside
AUPH
Aurinia Pharmaceuticals Inc
10% Upside
EDT
Spectral Medical Inc
127% Upside
ASND
Ascendis Pharma A/S
30% Upside

Revenue
Forecast

Revenue Estimate
Vitrolife AB

For the last 13 years the compound annual growth rate for Vitrolife AB's revenue is 20%. The projected CAGR for the next 4 years is 5%.

20%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vitrolife AB

For the last 13 years the compound annual growth rate for Vitrolife AB's operating income is 25%. The projected CAGR for the next 3 years is 8%.

25%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Vitrolife AB

For the last 13 years the compound annual growth rate for Vitrolife AB's net income is 24%. The projected CAGR for the next 4 years is 8%.

24%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VTFN's stock price target?
Price Target
16.77 EUR

According to Wall Street analysts, the average 1-year price target for VTFN is 16.77 EUR with a low forecast of 14.22 EUR and a high forecast of 21.26 EUR.

What is Vitrolife AB's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Vitrolife AB's revenue is 20%. The projected CAGR for the next 4 years is 5%.

What is Vitrolife AB's Operating Income forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Vitrolife AB's operating income is 25%. The projected CAGR for the next 3 years is 8%.

What is Vitrolife AB's Net Income forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Vitrolife AB's net income is 24%. The projected CAGR for the next 4 years is 8%.

Back to Top